Scott Gibson

Head of Device Technologies Innovation Center

Scott Gibson was recruited to Amgen in 2012 to build Amgen’s Advanced Device Technologies and Innovation Organization and since 2016 heads Amgen’s Device Technologies Innovation Center in Cambridge, Massachusetts. These organizations are responsible for identification and advancement of device technologies with application to Amgen’s product and portfolio strategies. Scott previously directed development for multiple drug delivery companies in treatment of diabetes, spasticity, and chronic pain resulting in acquisition by Medtronic and Boston Scientific. Scott earned his Bachelor's degree in Mechanical Engineering from California Polytechnic State University, San Luis Obispo, and currently holds 29 US patents in drug delivery and cardiac rhythm management.


Opening Address by the Chair

Thu, 07/02/2019 - 9:00am to 9:30am
Session Type: Conference
Session Track: Conference | Session 4: New in Biologicals and Biosimilar Drug Delivery Devices